Qingmei Shi

Qingmei Shi is the Chief Medical Officer at CStone Pharmaceuticals. Prior to this role, Qingmei served as Senior Vice President and Head of Clinical Development at the same company. Qingmei has an extensive background in medical monitoring, with experience as a Senior Medical Director at Covance and various roles at PAREXEL. Qingmei holds a PhD in Biology and medicine from the National University of Singapore, and a Doctor of Medicine in ENT oncology from ShanDong Medical University in China.